SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Vascular Solutions LLC (VASC) trades at a trailing P/E of 96.6. Trailing earnings yield is 1.04%.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 96.6).
- Trailing Earnings Yield 1.04% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 61/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VASC
Valuation Multiples
P/E (TTM)96.6
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio6.87
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.58
Book Value / Share$0.00
Revenue / Share$8.16
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.04%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2006 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2007 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2008 |
$1.04 |
$61.22M |
$16.17M |
26.4% |
| 2009 |
$0.34 |
$68.43M |
$5.38M |
7.9% |
| 2010 |
$1.26 |
$78.44M |
$21.38M |
27.3% |
| 2011 |
$0.57 |
$89.96M |
$9.74M |
10.8% |
| 2012 |
$0.60 |
$98.39M |
$9.91M |
10.1% |
| 2013 |
$0.65 |
$110.5M |
$11.14M |
10.1% |
| 2014 |
$0.72 |
$126.1M |
$12.73M |
10.1% |
| 2015 |
$0.58 |
$147.2M |
$10.46M |
7.1% |
